Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kanyarat Thueng-in, Jeeraphong Thanongsaksrikul, Surasak Jittavisutthikul, Watee Seesuay, Monrat Chulanetra, Yuwaporn Sakolvaree, Potjanee Srimanote & Wanpen Chaicumpa. (2014) Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. mAbs 6:5, pages 1327-1339.
Read now
Read now
Tabinda Burney & Geoffrey Dusheiko. (2011) Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients. Expert Review of Anti-infective Therapy 9:2, pages 151-160.
Read now
Read now
MariaCássia Mendes-Corrêa & Marina Núñez. (2010) Management of HIV and hepatitis virus coinfection. Expert Opinion on Pharmacotherapy 11:15, pages 2497-2516.
Read now
Read now
Wikrom Karnsakul, Mary Kay Alford & Kathleen B Schwarz. (2009) Managing pediatric hepatitis C: current and emerging treatment options. Therapeutics and Clinical Risk Management 5, pages 651-660.
Read now
Read now
Articles from other publishers (69)
Fatma Masmoudi, Nanci Santos-Ferreira, Dasja Pajkrt, Katja C. Wolthers, Jeroen DeGroot, Maria L. H. Vlaming, Joana Rocha-Pereira & Ludovico Buti. (2023) Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery. Cells 12:8, pages 1138.
Crossref
Crossref
Vineet Verma, Ankita Singh, Purnima Tyagi, Vijay Kumar & Ashok K. Prasad. (2023) Synthesis of 1,2,3‐Triazole‐Linked Hexopyranosylpyrimidine Nucleosides and Their Application as Hepatitis B Viral DNA, HBsAg and HBeAg Suppressants. ChemistrySelect 8:12.
Crossref
Crossref
Tomas Cihlar & Richard L. Mackman. (2022) Journey of remdesivir from the inhibition of hepatitis C virus to the treatment of COVID-19. Antiviral Therapy 27:2, pages 135965352210827.
Crossref
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannMichael J. Sofia. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses
13
57
.
Longhu Zhou, Hongwang Zhang, Chengwei Li, Coralie De Schutter, Ozkan Sari, Seema Mengshetti, Shaoman Zhou, Mahesh Kasthuri, Steven J. Coats, Raymond F. Schinazi & Franck Amblard. (2021) Diastereoselective Synthesis of 2′-Dihalopyrimidine Ribonucleoside Inhibitors of Hepatitis C Virus Replication. ACS Omega 7:1, pages 1452-1461.
Crossref
Crossref
Nicole Pribut, Michael D’Erasmo, Madhuri Dasari, Kyle E. Giesler, Sabrina Iskandar, Savita K. Sharma, Perry W. Bartsch, Akshay Raghuram, Anatoliy Bushnev, Soyon S. Hwang, Samantha L. Burton, Cynthia A. Derdeyn, Adriaan E. Basson, Dennis C. Liotta & Eric J. Miller. (2021) ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic Properties. Journal of Medicinal Chemistry 64:17, pages 12917-12937.
Crossref
Crossref
Abdullah Al Mamun Sohag, Md Abdul Hannan, Sadaqur Rahman, Motaher Hossain, Mahmudul Hasan, Md Kawsar Khan, Amena Khatun, Raju Dash & Md Jamal Uddin. (2020)
Revisiting potential druggable targets against
SARS‐CoV
‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
. Drug Development Research 81:8, pages 919-941.
Crossref
Crossref
Robert M. Cox, Julien Sourimant, Mart Toots, Jeong-Joong Yoon, Satoshi Ikegame, Mugunthan Govindarajan, Ruth E. Watkinson, Patricia Thibault, Negar Makhsous, Michelle J. Lin, Jose R. Marengo, Zachary Sticher, Alexander A. Kolykhalov, Michael G. Natchus, Alexander L. Greninger, Benhur Lee & Richard K. Plemper. (2020) Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase. Nature Microbiology 5:10, pages 1232-1246.
Crossref
Crossref
Volker Kinast, Thomas L Burkard, Daniel Todt & Eike Steinmann. (2019) Hepatitis E Virus Drug Development. Viruses 11:6, pages 485.
Crossref
Crossref
Seema Mengshetti, Longhu Zhou, Ozkan Sari, Coralie De Schutter, Hongwang Zhang, Jong Hyun Cho, Sijia Tao, Leda C. Bassit, Kiran Verma, Robert A. Domaoal, Maryam Ehteshami, Yong Jiang, Reuben Ovadia, Mahesh Kasthuri, Olivia Ollinger Russell, Tamara McBrayer, Tony Whitaker, Judy Pattassery, Maria Luz Pascual, Lothar Uher, Biing Y. Lin, Sam Lee, Franck Amblard, Steven J. Coats & Raymond F. Schinazi. (2019) Discovery of a Series of 2′-α-Fluoro,2′-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus. Journal of Medicinal Chemistry 62:4, pages 1859-1874.
Crossref
Crossref
Marcella Bassetto, Jana Van Dycke, Johan Neyts, Andrea Brancale & Joana Rocha-Pereira. (2019) Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy. Viruses 11:2, pages 173.
Crossref
Crossref
Michael J. Sofia & Phillip A. Furman. 2019. HCV: The Journey from Discovery to a Cure. HCV: The Journey from Discovery to a Cure
141
169
.
Jamie J. Arnold & Craig E. Cameron. 2018. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants
407
417
.
Gaofei Lu, Gregory R. Bluemling, Shuli Mao, Michael Hager, Bharat P. Gurale, Paul Collop, Damien Kuiper, Kasinath Sana, George R. Painter, Abel De La Rosa & Alexander A. Kolykhalov. (2018)
Simple
In Vitro
Assay To Evaluate the Incorporation Efficiency of Ribonucleotide Analog 5′-Triphosphates into RNA by Human Mitochondrial DNA-Dependent RNA Polymerase
. Antimicrobial Agents and Chemotherapy 62:2.
Crossref
Crossref
Joy Y Feng. (2018) Addressing the selectivity and toxicity of antiviral nucleosides. Antiviral Chemistry and Chemotherapy 26, pages 204020661875852.
Crossref
Crossref
Cyril B Dousson. (2018) Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection. Antiviral Chemistry and Chemotherapy 26, pages 204020661875643.
Crossref
Crossref
Ertong Li, Yafeng Wang, Wenquan Yu, Zhigang Lv, Youmei Peng, Bingjie Liu, Shiliang Li, Wenzhe Ho, Qingduan Wang, Honglin Li & Junbiao Chang. (2018) Synthesis and biological evaluation of a novel β-D-2′-deoxy-2′-α-fluoro-2′-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection. European Journal of Medicinal Chemistry 143, pages 107-113.
Crossref
Crossref
Shaoman Zhou, Sawsan Mahmoud, Peng Liu, Longhu Zhou, Maryam Ehteshami, Leda Bassit, Sijia Tao, Robert A. Domaoal, Ozkan Sari, Coralie De Schutter, Sheida Amiralaei, Ahmed Khalil, Olivia Ollinger Russell, Tamara McBrayer, Tony Whitaker, Nageh Abou-Taleb, Franck Amblard, Steven J. Coats & Raymond F. Schinazi. (2017) 2′-Chloro,2′-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture. Journal of Medicinal Chemistry 60:13, pages 5424-5437.
Crossref
Crossref
Zhinan Jin, April Kinkade, Ishani Behera, Shuvam Chaudhuri, Kathryn Tucker, Natalia Dyatkina, Vivek K. Rajwanshi, Guangyi Wang, Andreas Jekle, David B. Smith, Leo Beigelman, Julian A. Symons & Jerome Deval. (2017) Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs. Antiviral Research 143, pages 151-161.
Crossref
Crossref
Wikrom Karnsakul & Kathleen B. Schwarz. (2017) Hepatitis B and C. Pediatric Clinics of North America 64:3, pages 641-658.
Crossref
Crossref
Tim Bergbrede, Emily Hoberg, Nils-Göran Larsson, Maria Falkenberg & Claes M. Gustafsson. (2017) An Adaptable High-Throughput Technology Enabling the Identification of Specific Transcription Modulators. SLAS Discovery 22:4, pages 378-386.
Crossref
Crossref
M.J. Sofia & J.O. Link. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
558
582
.
Bianca Heinrich & John P. Bilello. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
579
609
.
Michael J. Sofia. 2016. Successful Drug Discovery. Successful Drug Discovery
163
188
.
Joy Y. Feng, Yili Xu, Ona Barauskas, Jason K. Perry, Shekeba Ahmadyar, George Stepan, Helen Yu, Darius Babusis, Yeojin Park, Krista McCutcheon, Michel Perron, Brian E. Schultz, Roman Sakowicz & Adrian S. Ray. (2016) Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus. Antimicrobial Agents and Chemotherapy 60:2, pages 806-817.
Crossref
Crossref
Luis E. Iglesias, Elizabeth S. Lewkowicz, Rosario Medici, Paola Bianchi & Adolfo M. Iribarren. (2015) Biocatalytic approaches applied to the synthesis of nucleoside prodrugs. Biotechnology Advances 33:5, pages 412-434.
Crossref
Crossref
Robert Cox & Richard K. Plemper. (2015) The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics. Frontiers in Microbiology 6.
Crossref
Crossref
Hassan RashidzadehSanjeev BhadresaSteven Spencer GoodMarita Larsson CohenKusum Sachdev GuptaWilliam Roger Rush. (2015) Overcoming Stability Challenges in the Quantification of Tissue Nucleotides: Determination of 2?-<i>C</i>-Methylguanosine Triphosphate Concentration in Mouse Liver. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:3, pages 380-388.
Crossref
Crossref
Pierre L. Beaulieu, Josie De Marte, Michel Garneau, Laibin Luo, Timothy Stammers, Chitra Telang, Dominik Wernic, George Kukolj & Jianmin Duan. (2015) A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS). Bioorganic & Medicinal Chemistry Letters 25:2, pages 210-215.
Crossref
Crossref
Pierre L. Beaulieu, Paul C. Anderson, Richard Bethell, Michael Bös, Yves Bousquet, Christian Brochu, Michael G. Cordingley, Gulrez Fazal, Michel Garneau, James R. Gillard, Stephen Kawai, Martin Marquis, Ginette McKercher, Marc-André Poupart, Timothy Stammers, Bounkham Thavonekham, Dominik Wernic, Jianmin Duan & George Kukolj. (2014) Discovery of BI 207524, an Indole Diamide NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection. Journal of Medicinal Chemistry 57:23, pages 10130-10143.
Crossref
Crossref
Michael R. Mish, Aesop Cho, Thorsten Kirschberg, Jie Xu, C. Sebastian Zonte, Martijn Fenaux, Yeojin Park, Darius Babusis, Joy Y. Feng, Adrian S. Ray & Choung U. Kim. (2014) Preparation and biological evaluation of 1?-cyano-2?-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters 24:14, pages 3092-3095.
Crossref
Crossref
Joy Y. Feng, Guofeng Cheng, Jason Perry, Ona Barauskas, Yili Xu, Martijn Fenaux, Stacey Eng, Neeraj Tirunagari, Betty Peng, Mei Yu, Yang Tian, Yu-Jen Lee, George Stepan, Leanna L. Lagpacan, Debi Jin, Magdeleine Hung, Karin S. Ku, Bin Han, Kathryn Kitrinos, Michel Perron, Gabriel Birkus, Kelly A. Wong, Weidong Zhong, Choung U. Kim, Anne Carey, Aesop Cho & Adrian S. Ray. (2014)
Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent
C
-Nucleoside Monophosphate Prodrug
. Antimicrobial Agents and Chemotherapy 58:4, pages 1930-1942.
Crossref
Crossref
Jinfa Du, Byoung-Kwon Chun, Ralph T. Mosley, Shalini Bansal, Haiying Bao, Christine Espiritu, Angela M. Lam, Eisuke Murakami, Congrong Niu, Holly M. Micolochick Steuer, Phillip A. Furman & Michael J. Sofia. (2013) Use of 2′-Spirocyclic Ethers in HCV Nucleoside Design. Journal of Medicinal Chemistry 57:5, pages 1826-1835.
Crossref
Crossref
Steven R. LaPlante, Michael Bös, Christian Brochu, Catherine Chabot, René Coulombe, James R. Gillard, Araz Jakalian, Martin Poirier, Jean Rancourt, Timothy Stammers, Bounkham Thavonekham, Pierre L. Beaulieu, George Kukolj & Youla S. Tsantrizos. (2013) Conformation-Based Restrictions and Scaffold Replacements in the Design of Hepatitis C Virus Polymerase Inhibitors: Discovery of Deleobuvir (BI 207127). Journal of Medicinal Chemistry 57:5, pages 1845-1854.
Crossref
Crossref
Steven J. Coats, Ethel C. Garnier-Amblard, Franck Amblard, Maryam Ehteshami, Sheida Amiralaei, Hongwang Zhang, Longhu Zhou, Sebastien R.L. Boucle, Xiao Lu, Lavanya Bondada, Jadd R. Shelton, Hao Li, Peng Liu, Chengwei Li, Jong Hyun Cho, Satish N. Chavre, Shaoman Zhou, Judy Mathew & Raymond F. Schinazi. (2014) Chutes and ladders in hepatitis C nucleoside drug development. Antiviral Research 102, pages 119-147.
Crossref
Crossref
Michael J. Sofia. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs
421
450
.
Jennifer J. KiserCharles Flexner. (2013) Direct-Acting Antiviral Agents for Hepatitis C Virus Infection. Annual Review of Pharmacology and Toxicology 53:1, pages 427-449.
Crossref
Crossref
Michael J. Sofia. 2013. Antiviral Agents. Antiviral Agents
39
73
.
David L. Wyles. (2012) Hepatitis C Virus Drug Resistance. Infectious Disease Clinics of North America 26:4, pages 967-978.
Crossref
Crossref
Jamie J. Arnold, Suresh D. Sharma, Joy Y. Feng, Adrian S. Ray, Eric D. Smidansky, Maria L. Kireeva, Aesop Cho, Jason Perry, Jennifer E. Vela, Yeojin Park, Yili Xu, Yang Tian, Darius Babusis, Ona Barauskus, Blake R. Peterson, Averell Gnatt, Mikhail Kashlev, Weidong Zhong & Craig E. Cameron. (2012) Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides. PLoS Pathogens 8:11, pages e1003030.
Crossref
Crossref
Lenore A. Pelosi, Stacey Voss, Mengping Liu, Min Gao & Julie A. Lemm. (2012) Effect on Hepatitis C Virus Replication of Combinations of Direct-Acting Antivirals, Including NS5A Inhibitor Daclatasvir. Antimicrobial Agents and Chemotherapy 56:10, pages 5230-5239.
Crossref
Crossref
Mei H. Chang, Lori A. Gordon & Horatio B. Fung. (2012) Boceprevir: A Protease Inhibitor for the Treatment of Hepatitis C. Clinical Therapeutics 34:10, pages 2021-2038.
Crossref
Crossref
Pierre L. Beaulieu, Michael Bös, Michael G. Cordingley, Catherine Chabot, Gulrez Fazal, Michel Garneau, James R. Gillard, Eric Jolicoeur, Steven LaPlante, Ginette McKercher, Martin Poirier, Marc-André Poupart, Youla S. Tsantrizos, Jianmin Duan & George Kukolj. (2012) Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV). Journal of Medicinal Chemistry 55:17, pages 7650-7666.
Crossref
Crossref
Toru Ishikawa, Tomoyuki Kubota, Hiroyuki Abe, Aiko Nagashima, Kanae Hirose, Tadayuki Togashi, Keiichi Seki, Terasu Honma, Toshiaki Yoshida & Tomoteru Kamimura. (2012) Efficacy of the regimen using twice-daily β-interferon followed by the standard of care for chronic hepatitis C genotype 1b with high viral load. Hepatology Research 42:9, pages 864-869.
Crossref
Crossref
Jamie J. Arnold, Eric D. Smidansky, Ibrahim M. Moustafa & Craig E. Cameron. (2012) Human mitochondrial RNA polymerase: Structure–function, mechanism and inhibition. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1819:9-10, pages 948-960.
Crossref
Crossref
Karolina Madela & Christopher McGuigan. (2012) Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs. Future Medicinal Chemistry 4:5, pages 625-650.
Crossref
Crossref
Min Ding, Feng He, Thomas W. Hudyma, Xiaofan Zheng, Michael A. Poss, John F. Kadow, Brett R. Beno, Karen L. Rigat, Ying-Kai Wang, Robert A. Fridell, Julie A. Lemm, Dike Qiu, Mengping Liu, Stacey Voss, Lenore A. Pelosi, Susan B. Roberts, Min Gao, Jay Knipe & Robert G. Gentles. (2012) Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2866-2871.
Crossref
Crossref
Michael J. Sofia, Wonsuk Chang, Phillip A. Furman, Ralph T. Mosley & Bruce S. Ross. (2012) Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase. Journal of Medicinal Chemistry 55:6, pages 2481-2531.
Crossref
Crossref
Jing Tong, You-wei Wang & Yuan-an Lu. (2012) New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy. Journal of Zhejiang University SCIENCE B 13:1, pages 56-82.
Crossref
Crossref
J.-M. Sun, S.-J. Kim, G.-W. Kim, J.-K. Rhee, N. D. Kim, H. Jung, J. Jeun, S.-H. Lee, S. H. Han, C. S. Shin & J.-W. Oh. (2011) Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway. Journal of Antimicrobial Chemotherapy 67:1, pages 49-58.
Crossref
Crossref
S.-C. C. Sun, A. Bae, X. Qi, J. Harris, K. A. Wong, M. D. Miller & H. Mo. (2011) Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-na?ve HCV patient isolates. Journal of Viral Hepatitis 18:12, pages 861-870.
Crossref
Crossref
Michael J Sofia. (2011) Nucleotide Prodrugs for HCV Therapy. Antiviral Chemistry and Chemotherapy 22:1, pages 23-49.
Crossref
Crossref
Christopher McGuigan, Karolina Madela, Mohamed Aljarah, Arnaud Gilles, Srinivas K. Battina, Changalvala V.S. Ramamurty, C. Srinivas Rao, John Vernachio, Jeff Hutchins, Andrea Hall, Alexander Kolykhalov, Geoffrey Henson & Stanley Chamberlain. (2011) Dual pro-drugs of 2′-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus. Bioorganic & Medicinal Chemistry Letters 21:19, pages 6007-6012.
Crossref
Crossref
Scott D. Seiwert, Karl Kossen, Lin Pan, Jyanwei Liu & Brad O. Buckman. 2011. Antiviral Drugs. Antiviral Drugs
257
271
.
Srinivas Gadthula, Ravindra K. Rawal, Ashoke Sharon, Dong Wu, Brent Korba & Chung K. Chu. (2011) Synthesis and antiviral activity of cyclopropyl-spirocarbocyclic adenosine, (4 R ,5 S ,6 R ,7 R )-4-(6-amino-9 H -purin-9-yl)-7-(hydroxymethyl)spiro[2.4]heptane-5,6-diol against hepatitis C virus. Bioorganic & Medicinal Chemistry Letters 21:13, pages 3982-3985.
Crossref
Crossref
Maria Letizia Barreca, Nunzio Iraci, Giuseppe Manfroni & Violetta Cecchetti. (2011)
Allosteric inhibition of the hepatitis C virus NS5B polymerase:
in silico
strategies for drug discovery and development
. Future Medicinal Chemistry 3:8, pages 1027-1055.
Crossref
Crossref
Pierre L. Beaulieu, Catherine Chabot, Jianmin Duan, Michel Garneau, James Gillard, Eric Jolicoeur, Martin Poirier, Marc-Andr? Poupart, Timothy A. Stammers, George Kukolj & Youla S. Tsantrizos. (2011) Indole 5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): Central amino acid linker and right-hand-side SAR studies. Bioorganic & Medicinal Chemistry Letters 21:12, pages 3664-3670.
Crossref
Crossref
Xiaofan Zheng, Thomas W. Hudyma, Scott W. Martin, Carl Bergstrom, Min Ding, Feng He, Jeffrey Romine, Michael A. Poss, John F. Kadow, Chong-Hwan Chang, John Wan, Mark R. Witmer, Paul Morin, Daniel M. Camac, Steven Sheriff, Brett R. Beno, Karen L. Rigat, Ying-Kai Wang, Robert Fridell, Julie Lemm, Dike Qiu, Mengping Liu, Stacey Voss, Lenore Pelosi, Susan B. Roberts, Min Gao, Jay Knipe & Robert G. Gentles. (2011) Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus. Bioorganic & Medicinal Chemistry Letters 21:10, pages 2925-2929.
Crossref
Crossref
James R. Beadle & Karl Y. Hostetler. 2011. Antiviral Drug Strategies. Antiviral Drug Strategies
181
208
.
Frank Narjes, Benedetta Crescenzi, Marco Ferrara, Jörg Habermann, Stefania Colarusso, Maria del Rosario Rico Ferreira, Ian Stansfield, Angela Claire Mackay, Immacolata Conte, Caterina Ercolani, Simone Zaramella, Maria-Cecilia Palumbi, Philip Meuleman, Geert Leroux-Roels, Claudio Giuliano, Fabrizio Fiore, Stefania Di Marco, Paola Baiocco, Uwe Koch, Giovanni Migliaccio, Sergio Altamura, Ralph Laufer, Raffaele De Francesco & Michael Rowley. (2010)
Discovery of (7
R
)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6
H
-indolo[1,2-
e
][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase
. Journal of Medicinal Chemistry 54:1, pages 289-301.
Crossref
Crossref
Steven R. LaPlante, James R. Gillard, Araz Jakalian, Norman Aubry, René Coulombe, Christian Brochu, Youla S. Tsantrizos, Martin Poirier, George Kukolj & Pierre L. Beaulieu. (2010) Importance of Ligand Bioactive Conformation in the Discovery of Potent Indole-Diamide Inhibitors of the Hepatitis C Virus NS5B. Journal of the American Chemical Society 132:43, pages 15204-15212.
Crossref
Crossref
Dawn McDowell Torres. (2010) Update on Specifically Targeted Antiviral Therapy for Hepatitis C Infection: Progress and Pitfalls on the Road to Viral Eradication. Current Hepatitis Reports 9:3, pages 125-132.
Crossref
Crossref
Christopher McGuiganArnaud GillesKarolina MadelaMohamed AljarahSabrina HollSarah JonesJohn Vernachio, Jeff Hutchins, Brenda Ames, K. Dawn Bryant, Elena Gorovits, Babita Ganguly, Damound Hunley, Andrea Hall, Alexander Kolykhalov, Yule Liu, Jerry Muhammad, Nicholas Raja, Robin Walters, Jin Wang, Stanley Chamberlain & Geoffrey Henson. (2010)
Phosphoramidate ProTides of 2′-
C
-Methylguanosine as Highly Potent Inhibitors of Hepatitis C Virus. Study of Their in Vitro and in Vivo Properties
. Journal of Medicinal Chemistry 53:13, pages 4949-4957.
Crossref
Crossref
Tanya ParkinsonDavid C Pryde. (2010) Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus. Future Medicinal Chemistry 2:7, pages 1181-1203.
Crossref
Crossref
M. V. RAGNI, K. E. SHERMAN & J. A. JORDAN. (2010) Viral pathogens. Haemophilia 16, pages 40-46.
Crossref
Crossref
Pierre L. Beaulieu, Nathalie Dansereau, Jianmin Duan, Michel Garneau, James Gillard, Ginette McKercher, Steven LaPlante, Lisette Lagacée, Louise Thauvette & George Kukolj. (2010) Benzimidazole Thumb Pocket I finger-loop inhibitors of HCV NS5B polymerase: Improved drug-like properties through C-2 SAR in three sub-series. Bioorganic & Medicinal Chemistry Letters 20:6, pages 1825-1829.
Crossref
Crossref
Pierre L. Beaulieu, Eric Jolicoeur, James Gillard, Christian Brochu, René Coulombe, Nathalie Dansereau, Jianmin Duan, Michel Garneau, Araz Jakalian, Peter Kühn, Lisette Lagacé, Steven LaPlante, Ginette McKercher, Stéphane Perrault, Martin Poirier, Marc-André Poupart, Timothy Stammers, Louise Thauvette, Bounkham Thavonekham & George Kukolj. (2010) N-Acetamideindolecarboxylic acid allosteric ‘finger-loop’ inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies. Bioorganic & Medicinal Chemistry Letters 20:3, pages 857-861.
Crossref
Crossref
Virginie Algay, Ishwar Singh & Frances Heaney. (2010) Nucleoside and nucleotide analogues by catalyst free Huisgen nitrile oxide–alkyne1,3-dipolar cycloaddition. Org. Biomol. Chem. 8:2, pages 391-397.
Crossref
Crossref
Karen F. Murray. 2010. Viral Hepatitis in Children. Viral Hepatitis in Children
67
87
.